Company: Eli Lilly & Company (LLY)
*DRIP Club Members are able to acquire or list a share of a company on the DRIP Exchange Page.
Company Profile: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly’s key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. -Morningstar.com-
Symbol: LLY
Recent Price: $802.69
Dividends: $5.20
Yield: 0.65%
Sector: Healthcare
Industry: Drug Manufacturers-General
Address & Company Phone #: Lilly Corporate Ctr. Indianapolis IN 46285, 317-276-2000
Transfer Agent: Equiniti Group plc. 800-833-8699
Moody’s Rating: A2
Minimum & Maximum Investment: $50 – $150,000/year
Investment Dates: Every 7 days beginning varies
Shares to Qualify: 1 Share or $1000
Fees: Div.: $3+3¢/sh. Cash: $5+3¢/sh. Cert: $0 Sells: by Mail or Phone for $15+10¢/sh.
52 Week High & Low: $915.54, $434.34